• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/116 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring

Patent holdings for IPC class C07D 295/116

Total number of patents in this class: 47

10-year publication summary

5
2
5
1
2
2
2
2
2
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
PTC Therapeutics, Inc.
475
4
Orsobio, Inc.
18
4
Xenthera, Inc.
4
3
Novartis AG
10263
2
University of Florida Research Foundation, Inc.
4173
2
VM Oncology LLC
4
2
Suzhou Pharmavan Cancer Research Center Co., Ltd.
9
2
F. Hoffmann-La Roche AG
7836
1
Genentech, Inc.
4099
1
Boehringer Ingelheim International GmbH
4493
1
Centre National de La Recherche Scientifique
11016
1
FUJIFILM Corporation
30512
1
California Institute of Technology
4043
1
DSM IP Assets B.V.
5376
1
The Johns Hopkins University
5875
1
Actelion Pharmaceuticals Ltd
497
1
Adeka Corporation
1376
1
Georgia State University Research Foundation, Inc.
358
1
Pharmaxis Ltd
32
1
Ruprecht-Karls-Universität Heidelberg
244
1
Other owners 15